Trial
NCT04305184
A Study to Assess ASP0598 Otic Solution Following Topical Application in the Ear in Subjects With Chronic Tympanic Membrane Perforation (CTMP)
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Astellas Pharma Global Development, Inc.
Collaborators
—
Condition
Chronic Tympanic Membrane Perforation
Intervention
ASP0598
Why stopped
Lack of Efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-25